ABN AMRO Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.18M Sell
53,478
-1,828
-3% -$147K 0.05% 125
2026
Q1
$4.84M Sell
55,306
-27,000
-33% -$2.59M 0.05% 116
2025
Q4
$7.9M Buy
82,306
+24,473
+42% +$2.38M 0.07% 105
2025
Q3
$5.48M Sell
57,833
-282
-0.5% -$25.9K 0.05% 110
2025
Q2
$5.1M Sell
58,115
-44,610
-43% -$3.78M 0.07% 89
2025
Q1
$9.22M Buy
102,725
+3,317
+3% +$297K 0.13% 71
2024
Q4
$7.86M Sell
99,408
-20,123
-17% -$1.74M 0.11% 75
2024
Q3
$10.7M Buy
119,531
+25,442
+27% +$2.14M 0.15% 70
2024
Q2
$7.47M Sell
94,089
-406,756
-81% -$33.3M 0.11% 72
2024
Q1
$43.7M Buy
500,845
+24,830
+5% +$2.12M 0.65% 34
2023
Q4
$39.4M Buy
476,015
+23,972
+5% +$1.83M 0.65% 35
2023
Q3
$35.4M Buy
452,043
+7,457
+2% +$624K 0.64% 33
2023
Q2
$39.3M Buy
444,586
+10,712
+2% +$922K 0.8% 25
2023
Q1
$35M Buy
+433,874
New +$35.4M 0.78% 24

Other funds holding MDT

ABN AMRO Bank's MDT Position: Q2 2026 in Review

ABN AMRO Bank reduced its Medtronic (MDT) stake by 3.3% in Q2 2026, selling an estimated $147K and leaving 53,478 shares worth $4.18M. The position accounts for 0.05% of the portfolio, ranked #125.

ABN AMRO Bank first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $43.7M in Q1 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • ABN AMRO Bank held 53,478 shares of Medtronic worth $4.18M as of Q2 2026.
  • ABN AMRO Bank sold 1,828 Medtronic shares in Q2 2026, an estimated $147K.
  • Medtronic made up 0.05% of ABN AMRO Bank's portfolio in Q2 2026, its #125 holding.
  • ABN AMRO Bank first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Bank's Medtronic position peaked at $43.7M in Q1 2024.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.